Biomedical

Mayo Clinic is partnering with United Therapeutics to build a $41 million lung restoration center in Jacksonville, Fla. Located on Mayo’s Southside campus, the three-story, 75,000-sf facility will support the optimization of lungs destined for transplantation, as well as providing offices, conference rooms, and biomedical research space. Whiting-Turner will begin construction on the project in late 2017 with occupancy expected in spring of 2019. 

The College of New Jersey opened the $75 million STEM Building in October of 2017 in Ewing Township. Supporting programs in science, technology, engineering, and mathematics, the 89,000-sf facility houses the departments of biomedical engineering, mechanical engineering, and computer science. Designed by EYP Architecture & Engineering to provide integrated teaching and research space, the multidisciplinary building offers classrooms, informal learning areas, a metal fabrication workshop, and a physiology lab.

Cold Spring Harbor Laboratory broke ground in October of 2017 on the $75 million Center for Therapeutics Research in Cold Spring Harbor, N.Y. The project includes renovation of the existing Demerec Lab to create a 26,000-sf facility accommodating collaborative research in biology, chemistry, and genomics. The center will support the development of treatments for cancer, diabetes, leukemia, autism, and obesity. Completion is expected in late 2018.

Tufts University opened the 177,000-gsf Science and Engineering Complex in October of 2017 in Boston. The $110 million project included construction of a five-story, 79,000-sf facility and the renovation of two adjoining halls. Designed to promote collaborative research in life science, neuroscience, and environmental science, the new building provides three floors of wet research space, four core facilities, two imaging suites, a mass spectrometer suite, four teaching labs, and seven meeting rooms.

Sartorius Stedim Cellca is constructing a $35 million Cell Culture Technology Center in Ulm, Germany. Located at Science Park III in Eselsberg, the lab and office facility will support the development of cell culture and protein production technologies. Completion is expected in 2019. 

Vanderbilt University’s new Engineering and Science Building (ESB) brings the physical sciences and engineering together to expand interdisciplinary research in biomedical engineering, energy, and materials; recruit faculty in areas of nanotechnology and environmental engineering; and create a new undergraduate research-focused culture on campus.

Wexford Science & Technology broke ground in late September of 2017 on a $158 million innovation center in Providence, R.I. Cambridge Innovation Center and Brown University's School of Professional Studies have signed leases for space in the 191,000-sf facility, which will include civic and nonprofit conference venues, meeting rooms, and a café. Wexford is working with developer CV Properties of Boston on the delivery of the project. 

Roche Diagnostics has leased research space in NB Development Group’s Boston Landing. Roche will take occupancy of the approximately 29,000-sf facility, which is located in a 246,405-sf structure at 80 Guest Street, in early 2018. Proteostasis Therapeutics will also occupy a similar footprint in the building in early 2018.

Ferring Pharmaceuticals is planning to construct a 124,000-sf headquarters and research facility in Copenhagen. Designed by Foster + Partners, the facility will provide collaborative biopharmaceutical labs and offices to support the development of innovative products in the fields of reproductive health, urology, gastroenterology, endocrinology, and orthopedics. The building will include six stories above grade and two basement levels.

Monash University is constructing the Biomedical Learning and Teaching Building in Victoria. Designed by Denton Corker Marshall, the $81 million facility will feature four flexible labs that can be configured and conjoined to accommodate 60, 120, or 240 students. Supporting programs in microbiology, anatomy, biochemistry, immunology, and physiology, the 123,700-sf building will provide Physical Containment Level 2 (PC2) labs, technology-rich dissection labs, breakout spaces, and a 12,900-sf informal learning hub.

The Abbey Group is planning to construct Exchange South End, a 1.6 million-sf bioscience research campus located on the site of the Boston Flower Exchange. Designed by Stantec, the mixed-use development will provide approximately 841,000 sf of research space and 640,000 of office space. Arranged around a 30,000-sf public park, the four-building project will include:

Michigan State University opened the $88.1 million Grand Rapids Research Center in September of 2017. The six-story, 162,800-sf project provides the College of Human Medicine with open laboratories to support up to 44 biomedical research teams. Designed and engineered by SmithGroupJJR with Ellenzweig as laboratory design consultant, the vibration-mitigated facility features core labs for flow cytometry, bioinformatics, and microscopy.

The University of Maryland completed construction of the $169 million A. James Clark Hall in September of 2017 in College Park. Designed by Ballinger, the collaborative 184,000-sf facility houses the Department of Bioengineering and the Institute for Biomedical Devices. The multidisciplinary building offers flex classrooms, a vivarium, an atrium, flexible wet and dry labs, a high-bay innovation lab, and space for programs in biology, information technology, and mechanical engineering.

Boston University opened the $140 million Center for Integrated Life Sciences and Engineering (CILSE) in September of 2017. Designed by Payette, the nine-story, 170,000-sf facility houses the Center for Systems Neuroscience, the Biological Design Center, the Center for Cognitive Neuroimaging, and the Center for Sensory Communication and Neuroengineering Technology. The interdisciplinary building features a human Functional Magnetic Resonance Imaging (fMRI) suite, a Siemens 3 Tesla MRI, and space for behavioral testing and computational research.

SAB Biotherapeutics began construction in August of 2017 on an agricultural production facility for antibody therapeutics. The 80-acre ‘pharm’ will accommodate transgenic cattle which produce plasma in reaction to a vaccine, providing a source of natural human polyclonal antibodies. The facility is located adjacent to SAB’s existing corporate headquarters and is slated for completion in spring of 2018.